Literature DB >> 16085366

Changes in HIV risk behaviors among patients receiving combined pharmacological and behavioral interventions for heroin and cocaine dependence.

Jennifer R Schroeder1, David H Epstein, Annie Umbricht, Kenzie L Preston.   

Abstract

Cocaine use is associated with injecting and sexual HIV risk behaviors. This study was a randomized controlled trial of behavioral interventions for cocaine dependence and HIV risk behaviors among dually (cocaine and heroin) dependent outpatients. Methadone maintenance was augmented with cognitive-behavioral therapy (CBT), contingency management (CM), both (CBT+CM), or neither. The study sample (n=81) was 52% female, 70% African American, and 37.9+/-7.0 years old. Proportions reporting HIV risk behaviors at intake were: 96.3% (78/81) injection drug use, 56.8% (46/81) sharing needles, 30.9% (25/81) unprotected sex, 28.4% (23/81) trading sex for money or drugs. Proportions who no longer reported behaviors at study exit were: 51.3% (40/78) injection drug use, 91.3% (42/46) sharing needles, 88% (22/25) unprotected sex, 91.3% (21/23) trading sex for money or drugs. Participants receiving CBT+CM were more likely to report cessation of unprotected sex relative to control (OR=5.44, 95% CI 1.14-26.0, p=0.034) but this effect was no longer significant after adjusting for drug-negative urines. These results suggest broad beneficial effects of methadone maintenance augmented with behavioral interventions for reducing HIV risk behaviors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16085366     DOI: 10.1016/j.addbeh.2005.07.009

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  30 in total

Review 1.  Contingency management interventions for HIV-related behaviors.

Authors:  Nancy A Haug; James L Sorensen
Journal:  Curr HIV/AIDS Rep       Date:  2006-11       Impact factor: 5.071

2.  Barriers to providing health services for HIV/AIDS, hepatitis C virus infection and sexually transmitted infections in substance abuse treatment programs in the United States.

Authors:  Edmund J Bini; Steven Kritz; Lawrence S Brown; Jim Robinson; Don Alderson; John Rotrosen
Journal:  J Addict Dis       Date:  2011-04

Review 3.  Individually randomized group treatment trials: a critical appraisal of frequently used design and analytic approaches.

Authors:  Sherri L Pals; David M Murray; Catherine M Alfano; William R Shadish; Peter J Hannan; William L Baker
Journal:  Am J Public Health       Date:  2008-06-12       Impact factor: 9.308

4.  The Chinese government's response to drug use and HIV/AIDS: a review of policies and programs.

Authors:  Jianhua Li; Toan H Ha; Cunmin Zhang; Hongjie Liu
Journal:  Harm Reduct J       Date:  2010-03-05

5.  Continuing Care and Trauma in Women Offenders' Substance Use, Psychiatric Status, and Self-Efficacy Outcomes.

Authors:  Preeta Saxena; Christine E Grella; Nena P Messina
Journal:  Women Crim Justice       Date:  2015-10-01

Review 6.  Prevention of HIV infection among injection drug users in resource-limited settings.

Authors:  David Vlahov; Angela M Robertson; Steffanie A Strathdee
Journal:  Clin Infect Dis       Date:  2010-05-15       Impact factor: 9.079

Review 7.  Conditional economic incentives for reducing HIV risk behaviors: integration of psychology and behavioral economics.

Authors:  Don Operario; Caroline Kuo; Sandra G Sosa-Rubí; Omar Gálarraga
Journal:  Health Psychol       Date:  2013-09       Impact factor: 4.267

8.  Gender differences in health related quality of life of young heroin users.

Authors:  Antònia Domingo-Salvany; M Teresa Brugal; Gregorio Barrio; Francisco González-Saiz; M José Bravo; Luís de la Fuente
Journal:  Health Qual Life Outcomes       Date:  2010-12-01       Impact factor: 3.186

9.  Group-based randomized trial of contingencies for health and abstinence in HIV patients.

Authors:  Nancy M Petry; Jeremiah Weinstock; Sheila M Alessi; Marilyn W Lewis; Kevin Dieckhaus
Journal:  J Consult Clin Psychol       Date:  2010-02

10.  Contingency management reduces injection-related HIV risk behaviors in heroin and cocaine using outpatients.

Authors:  Udi E Ghitza; David H Epstein; Kenzie L Preston
Journal:  Addict Behav       Date:  2007-11-17       Impact factor: 3.913

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.